Emmaus Life Sciences Announces First Purchase Order from its Partnership with taiba Healthcare

TORRANCE, Calif., Dec. 31, 2019 (GLOBE NEWSWIRE) -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, today reported that it received the initial purchase order relating to taiba Healthcarea??s early access program for EndariA® (L-glutamine oral powder) in Oman. Based in the Sultanate of Oman, taiba is a leading healthcare marketing, distribution and retail pharmacy group focused on the Gulf Cooperation Countries (Saudi Arabia, Kuwait, the United Arab Emirates, Bahrain and Oman). This region represents a large market for Endari, with Saudi Arabia alone having more patients afflicted with sickle cell disease than in the United States.
Dr. Yutaka Niihara, M.D., M.P.H., Chairman and Chief Executive Officer of Emmaus commented, a??we are very pleased to have received this initial purchase order attributable to our partnership with taiba and, together, look forward to serving the needs of sickle cell disease patients and their healthcare providers throughout the very important MENA region.a??a??This is an exciting milestone for Emmaus Life Sciences and the culmination of the commitment made to sickle cell disease patients not only in the United States, but worldwide. Oman is a key partner country and a valued ally in the treatment of SCD patients,a?? added George Sekulich, Senior Vice President of A Global Commercialization.About Emmaus Life Sciences
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories.A  For more information, please visit EndariA® (L-glutamine oral powder)
Indication - Endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »